MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $622,765 | -68.2% | 16,750 | -61.3% | 0.13% | -74.6% |
| Q4 2022 | $1,960,292 | +429.8% | 43,264 | +2466.1% | 0.51% | +501.2% |
| Q1 2021 | $370,000 | 0.0% | 1,686 | 0.0% | 0.08% | +1.2% |
| Q4 2020 | $370,000 | +72.9% | 1,686 | +31.1% | 0.08% | +82.6% |
| Q3 2020 | $214,000 | -92.9% | 1,286 | -95.6% | 0.05% | -71.1% |
| Q2 2019 | $3,017,000 | – | 29,291 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |